A Phase II clinical trial of Gemcitabine and Erlotinib with or without Oxaliplatin in previously untreated Patients With advanced Pancreatic Cancer.
Latest Information Update: 17 Sep 2021
At a glance
- Drugs Erlotinib (Primary) ; Gemcitabine (Primary) ; Oxaliplatin (Primary)
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Therapeutic Use
- 17 Sep 2021 New trial record
- 01 Aug 2021 Results published in the Yonsei Medical Journal